289 related articles for article (PubMed ID: 10785223)
1. Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism.
Pigny P; Cortet-Rudelli C; Decanter C; Deroubaix D; Soudan B; Duhamel A; Dewailly D
Fertil Steril; 2000 May; 73(5):972-7. PubMed ID: 10785223
[TBL] [Abstract][Full Text] [Related]
2. Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome.
Cortet-Rudelli C; Pigny P; Decanter C; Leroy M; Maunoury-Lefebvre C; Thomas-Desrousseaux P; Dewailly D
Fertil Steril; 2002 Feb; 77(2):281-7. PubMed ID: 11821084
[TBL] [Abstract][Full Text] [Related]
3. High serum concentration of total inhibin in polycystic ovary syndrome.
Tsigkou A; Luisi S; De Leo V; Patton L; Gambineri A; Reis FM; Pasquali R; Petraglia F
Fertil Steril; 2008 Nov; 90(5):1859-63. PubMed ID: 18423626
[TBL] [Abstract][Full Text] [Related]
4. Müllerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B.
Chu MC; Carmina E; Wang J; Lobo RA
Fertil Steril; 2005 Dec; 84(6):1685-8. PubMed ID: 16359965
[TBL] [Abstract][Full Text] [Related]
5. Serum alpha-inhibin levels in polycystic ovary syndrome: relationship to the serum androstenedione level.
Pigny P; Desailloud R; Cortet-Rudelli C; Duhamel A; Deroubaix-Allard D; Racadot A; Dewailly D
J Clin Endocrinol Metab; 1997 Jun; 82(6):1939-43. PubMed ID: 9177410
[TBL] [Abstract][Full Text] [Related]
6. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
7. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
8. Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism.
Castelo-Branco C; Steinvarcel F; Osorio A; Ros C; Balasch J
Gynecol Endocrinol; 2010 Oct; 26(10):736-42. PubMed ID: 20569105
[TBL] [Abstract][Full Text] [Related]
9. Serum inhibin B in polycystic ovary syndrome: regulation by insulin and luteinizing hormone.
Welt CK; Taylor AE; Martin KA; Hall JE
J Clin Endocrinol Metab; 2002 Dec; 87(12):5559-65. PubMed ID: 12466353
[TBL] [Abstract][Full Text] [Related]
10. Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome.
Wachs DS; Coffler MS; Malcom PJ; Shimasaki S; Chang RJ
J Clin Endocrinol Metab; 2008 May; 93(5):1827-33. PubMed ID: 18285408
[TBL] [Abstract][Full Text] [Related]
11. Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome.
Piltonen T; Koivunen R; Perheentupa A; Morin-Papunen L; Ruokonen A; Tapanainen JS
J Clin Endocrinol Metab; 2004 Aug; 89(8):3769-75. PubMed ID: 15292303
[TBL] [Abstract][Full Text] [Related]
12. Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis.
Welt CK; Taylor AE; Fox J; Messerlian GM; Adams JM; Schneyer AL
J Clin Endocrinol Metab; 2005 Oct; 90(10):5582-7. PubMed ID: 16030174
[TBL] [Abstract][Full Text] [Related]
13. Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility.
Laven JS; Imani B; Eijkemans MJ; de Jong FH; Fauser BC
Hum Reprod; 2001 Jul; 16(7):1359-64. PubMed ID: 11425813
[TBL] [Abstract][Full Text] [Related]
14. Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.
Yetim A; Yetim Ç; Baş F; Erol OB; Çığ G; Uçar A; Darendeliler F
J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):288-97. PubMed ID: 27125339
[TBL] [Abstract][Full Text] [Related]
15. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
16. [Serum inhibin B in polycystic ovary syndrome as a potential marker of ovarian dysfunction].
Cetković A
Srp Arh Celok Lek; 2008; 136(7-8):379-83. PubMed ID: 18959173
[TBL] [Abstract][Full Text] [Related]
17. Androgen excess contributes to altered growth hormone/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome.
Wu X; Sallinen K; Zhou S; Su Y; Pöllänen P; Erkkola R
Fertil Steril; 2000 Apr; 73(4):730-4. PubMed ID: 10731533
[TBL] [Abstract][Full Text] [Related]
18. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.
Li L; Chen X; He Z; Zhao X; Huang L; Yang D
J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):390-5. PubMed ID: 23089573
[TBL] [Abstract][Full Text] [Related]
19. Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome.
Eldar-Geva T; Spitz IM; Groome NP; Margalioth EJ; Homburg R
Hum Reprod; 2001 Dec; 16(12):2552-6. PubMed ID: 11726573
[TBL] [Abstract][Full Text] [Related]
20. Serum inhibin pro alphaC in infertile men.
Fujisawa M; Yamazaki I; Dobashi M; Okada H; Kamidono S
Arch Androl; 2001; 47(3):191-4. PubMed ID: 11695842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
